MSK Awards and Appointments February 2024
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Yael David Awarded 2024 Alfred P. Sloan Research Fellowship
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Yael David Awarded 2024 Alfred P. Sloan Research Fellowship
HHV-6B reactivation affects approximately half of all allogeneic hematopoietic cell transplant (HCT) recipients. HHV-6B is the most frequent infectious cause of encephalitis following HCT and…
Background: B-cell acute lymphoblastic leukemia (B-ALL) is the most common childhood malignancy. Medullary and extramedullary disease relapse is a well-known occurrence in B-ALL pediatric patients…
Kara N. Maxwell, MD, PhD, discusses strategies to optimize the utility of genetic testing to better inform decision-making in prostate cancer treatment.
What does ovarian cancer pain feel like? Gynecologic oncologist and surgeon Pamela Soliman, M.D., weighs in on this and four other questions.
Dr. Bose discusses the key findings from the COMFORT I and II trials and how the overall survival data has impacted the way he manages…
2023 Featured Articles July 13 – Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial Citation: van Hemert,…
An abstract is unavailable.
Health Canada has approved pembrolizumab plus chemotherapy for first-line, locally advanced, unresectable, or metastatic, HER2-negative gastric/GEJ cancer.
Registration for the OncoAlert ASCO 5k to be held on June 1st, 2024 at 7am local time and will start at the Hyatt Regency McCormick…
The FDA has mandated that the boxed warning for all approved CAR T-cell therapies be updated to include the serious risk of T-cell malignancies.